Serum and Saliva Protein Levels in Females with Breast Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2014 Nov 4

PMID 25364460

Citations 10

Authors

Sabah Isa Al-Muhtaseb

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the change in the total protein content between the serum and saliva of female patients with breast cancer and in healthy females. The study was conducted between October 2012 and November 2013. There were 80 females in the present study with 40 breast cancer patients and 40 healthy control subjects, with an age range of 50-70 years. The results of the study showed that the mean value ± standard deviation of the total serum protein in patients with breast cancer was 7.63±0.41 g/dl, whereas in the healthy subjects it was 6.14±1.84 g/dl. The total salivary protein measurement was 0.14±0.07 g/dl and 0.25±0.09 g/dl in the breast cancer and healthy group, respectively. Therefore, it can be concluded that the total serum protein was higher in female patients with breast cancer, whereas the levels in the saliva were lower compared to the healthy female group. The results of the present study indicate that serum protein levels may be used for the diagnosis of breast cancer.

Citing Articles

Extracting Knowledge from Machine Learning Models to Diagnose Breast Cancer.

Martinez-Ramirez J, Carmona C, Ramirez-Exposito M, Martinez-Martos J Life (Basel). 2025; 15(2).

PMID: 40003620 PMC: 11856414. DOI: 10.3390/life15020211.

Proteomics analysis of carcinogenesis in a rat model of mammary cancer induced by DMBA (7,12-dimethylbenz[a]anthracene).

Pratama D, Cahyati A, Kustiati U, Hardian A, Permata F F1000Res. 2024; 12:606.

PMID: 39070120 PMC: 11282392. DOI: 10.12688/f1000research.132524.1.

Isolation and Characterization of Extracellular Vesicles in Human Bowel Lavage Fluid.

Alorda-Clara M, Reyes J, Trelles-Guzman M, Florido M, Roca P, Pons D Int J Mol Sci. 2023; 24(8).

PMID: 37108550 PMC: 10138310. DOI: 10.3390/ijms24087391.

Biochemical Evaluation of Carbonic Anhydrase and Some Antioxidant Markers in Patients with Diabetes Complications.

Sulaiman A, Ghassan Z, Omar T Arch Razi Inst. 2022; 77(1):169-178.

PMID: 35891725 PMC: 9288634. DOI: 10.22092/ARI.2021.356308.1817.

Prognostic Value of Salivary Biochemical Indicators in Primary Resectable Breast Cancer.

Belskaya L, Sarf E Metabolites. 2022; 12(6).

PMID: 35736486 PMC: 9227854. DOI: 10.3390/metabo12060552.

References

Ozturk L, Emekli-Alturfan E, Kasikci E, Demir G, Yarat A . Salivary total sialic acid levels increase in breast cancer patients: a preliminary study. Med Chem. 2011; 7(5):443-7. DOI: 10.2174/157340611796799230. View

Santamaria-Kisiel L, Rintala-Dempsey A, Shaw G . Calcium-dependent and -independent interactions of the S100 protein family. Biochem J. 2006; 396(2):201-14. PMC: 1462724. DOI: 10.1042/BJ20060195. View

Haeckel R, Hanecke P . Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem. 1996; 34(3):171-91. View

Lee Y, Wong D . Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009; 22(4):241-8. PMC: 2860957. View

Kuerer H, Thompson P, Krishnamurthy S, Fritsche H, Marcy S, Babiera G . High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res. 2003; 9(2):601-5. View

Oppenheim F, Salih E, Siqueira W, Zhang W, Helmerhorst E . Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci. 2007; 1098:22-50. DOI: 10.1196/annals.1384.030. View

Doumas B, Bayse D, Carter R, PETERS Jr T, Schaffer R . A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem. 1981; 27(10):1642-50. View

Yilmaz I, Akcay T, Cakatay U, Telci A, Ataus S, Yalcin V . Relation between bladder cancer and protein oxidation. Int Urol Nephrol. 2004; 35(3):345-50. DOI: 10.1023/b:urol.0000022920.93994.ba. View

Pink R, Simek J, Vondrakova J, Faber E, Michl P, Pazdera J . Saliva as a diagnostic medium. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009; 153(2):103-10. DOI: 10.5507/bp.2009.017. View

10.

Siqueira W, Dawes C . The salivary proteome: challenges and perspectives. Proteomics Clin Appl. 2011; 5(11-12):575-9. DOI: 10.1002/prca.201100046. View

11.

Helmerhorst E, Oppenheim F . Saliva: a dynamic proteome. J Dent Res. 2007; 86(8):680-93. DOI: 10.1177/154405910708600802. View

12.

Bigler L, Streckfus C, Dubinsky W . Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin Lab Med. 2009; 29(1):71-85. DOI: 10.1016/j.cll.2009.01.004. View

13.

Colditz G, Frazier A . Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev. 1995; 4(5):567-71. View

14.

Halliwell B . Antioxidants: the basics--what they are and how to evaluate them. Adv Pharmacol. 1997; 38:3-20. DOI: 10.1016/s1054-3589(08)60976-x. View

15.

Kazmi S, Naglik J, Sweet S, Evans R, OShea S, Banatvala J . Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol. 2006; 13(10):1111-8. PMC: 1595323. DOI: 10.1128/CDLI.00426-05. View

16.

Parkin D, Muir C . Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ. 1992; (120):45-173. View

17.

Castagnola M, Cabras T, Vitali A, Sanna M, Messana I . Biotechnological implications of the salivary proteome. Trends Biotechnol. 2011; 29(8):409-18. DOI: 10.1016/j.tibtech.2011.04.002. View

18.

Macmahon B . Epidemiology and the causes of breast cancer. Int J Cancer. 2005; 118(10):2373-8. DOI: 10.1002/ijc.21404. View

19.

Yan W, Apweiler R, Balgley B, Boontheung P, Bundy J, Cargile B . Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl. 2009; 3(1):116-134. PMC: 2773554. DOI: 10.1002/prca.200800140. View

20.

Gao W, Kuick R, Orchekowski R, Misek D, Qiu J, Greenberg A . Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer. 2005; 5:110. PMC: 1198221. DOI: 10.1186/1471-2407-5-110. View